With cases of covid infection increasing in the country, Bihar’s first casualty happened this year in Gaya district, late on Friday night.
“The deceased is a 70-year-old woman, a native of Makhdumpur village in Gaya district. She was admitted to Magadh medical college and Hospital in Gaya three days ago after the complaint of uneasiness in breathing,” said Dr Ranjan Kumar Singh, civil surgeon of Gaya.
During the treatment, doctors conducted an RTPCR test where she turned out positive. We have initiated the process of cremation according to the Covid 19 protocols,” he said.
This is the first case of death due to corona in Gaya in the last 2 years.
The officer further said that there are 8 covid positive patients who are admitted to hospitals in the district and are undergoing treatment,” Singh said.
UP reports first Covid death of 2023
Uttar Pradesh has reported its first Covid death of this year.
An elderly woman, a resident of Vrindavan Colony, had tested positive for the virus on April 2 and died while undergoing treatment on Thursday.
She was also diagnosed with multiple organ failure.
“The woman was later shifted to King George’s Medical University where a second sample for Covid test was taken on April 4. The report of the second sample is awaited,” said a senior health official.
Since the pandemic first erupted in early 2020, Lucknow has reported 2,701 Covid deaths, while the overall fatality toll in Uttar Pradesh stood at 23,650.
Meanwhile, officials have said once the confirmatory report of the sample taken at KGMU comes, the death toll would be updated.
In the last 24 hours, the state reported 192 fresh Covid cases, while 68 patients recovered, including one in Lucknow.
Vaccines for cancer, heart disease to be ready by end of decade
Millions of lives could be saved by a groundbreaking set of new vaccines for a range of conditions including cancer, experts have said.
A leading pharmaceutical firm said it is confident that jabs for cancer, cardiovascular and autoimmune diseases, and other conditions will be ready by 2030, the Guardian reported.
Studies into these vaccinations are also showing “tremendous promise”, with some researchers saying 15 years’ worth of progress has been “unspooled” in 12 to 18 months thanks to the success of the Covid jab.
Paul Burton, the chief medical officer of pharmaceutical company Moderna, said he believes the firm will be able to offer such treatments for “all sorts of disease areas” in as little as five years.
The firm, which created a leading coronavirus vaccine, is developing cancer vaccines that target different tumour types, the Guardian reported.
Burton said: “We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands if not millions of lives. I think we will be able to offer personalised cancer vaccines against multiple different tumour types to people around the world.”
He also said that multiple respiratory infections could be covered by a single injection — allowing vulnerable people to be protected against Covid, flu and respiratory syncytial virus (RSV) — while mRNA therapies could be available for rare diseases for which there are currently no drugs, the Guardian reported.
Therapies based on mRNA work by teaching cells how to make a protein that triggers the body’s immune response against disease.
